Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

ClinicalTrials.gov ID: NCT00027820

Public ClinicalTrials.gov record NCT00027820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 5:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Low-Dose TBI and Fludarabine Followed by Nonmyeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation Using Enhanced Postgrafting Immunosuppression for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-center Trial

Study identification

NCT ID: NCT00027820
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Fred Hutchinson Cancer Center; Other
Enrollment: 106 participants

Conditions and interventions

Conditions

Interventions

Cyclosporine Drug
Fludarabine Phosphate Drug
Mycophenolate Mofetil Drug
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Procedure
Peripheral Blood Stem Cell Transplantation Procedure
Total-Body Irradiation Radiation

Drug · Procedure · Radiation

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2001
Primary completion: Aug 31, 2004
Completion: Sep 4, 2004
Last update posted: Dec 19, 2019

2001 – 2004

United States locations

U.S. sites: 8
U.S. states: 8
U.S. cities: 8

Facility	City	State	ZIP	Site status
University of Arizona Health Sciences Center	Tucson	Arizona	85724	—
Stanford University Hospitals and Clinics	Stanford	California	94305	—
Emory University/Winship Cancer Institute	Atlanta	Georgia	30322	—
OHSU Knight Cancer Institute	Portland	Oregon	97239	—
Baylor Medical Center at Garland	Garland	Texas	75042	—
Huntsman Cancer Institute/University of Utah	Salt Lake City	Utah	84112	—
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium	Seattle	Washington	98109	—
Froedtert and the Medical College of Wisconsin	Milwaukee	Wisconsin	53226	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00027820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 19, 2019 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00027820 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →